◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksA › ALC

Alcon AG (ALC) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-09-19

Alcon AG (ALC) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Geneva, Switzerland with about 25,000 employees. Its market capitalization is roughly $31 billion. In the fiscal year ended 2025-12-31, ALC reported $10.4B in revenue and $980M in net income.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care.

Interactive charts & full statements → Open the ALC valuation workbench →

ALC Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Total Revenue$10.8B$10.4B$9.9B$9.5B$8.7B$8.3B$6.8B$7.5B$7.2B$6.8B$6.6B$6.5B
Gross Profit$6.1B$5.7B$5.5B$5.2B$4.7B$4.7B$2.9B$3.7B$3.2B$3.2B$3.1B$3.1B
Gross Margin %56.5%55.2%55.6%55.5%54.5%56.1%43.0%48.8%44.6%47.2%47.2%47.9%
Operating Income (EBIT)$1.4B$1.4B$1.0B$672M$580M($482M)($187M)($248M)($77M)$10M$401M
Operating Margin %13.1%14.3%11.0%7.7%7.0%-7.0%-2.5%-3.5%-1.1%0.1%6.2%
Net Income$639M$980M$1.0B$974M$335M$376M($531M)($656M)($227M)$256M($170M)$296M
Net Margin %5.9%9.4%10.3%10.3%3.8%4.5%-7.8%-8.7%-3.2%3.8%-2.6%4.5%
EBITDA$2.4B$2.7B$2.2B$1.8B$1.8B$1.2B$1.3B$1.4B$1.2B$1.2B$1.6B
Earnings Per Share (EPS)$1.30$1.98$2.05$1.96$0.68$0.76$-1.09$-1.34$-0.46$0.52$-0.35$0.61
Shares Outstanding (M)496M498M496M494M493M489M488M489M489M489M489M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$2.8B$2.7B$2.7B$2.6B$2.6B$2.5B$2.5B$2.5B$2.5B
Gross Profit$1.7B$1.5B$1.5B$1.5B$1.4B$1.4B$1.4B$1.4B$1.4B
Gross Margin %59.3%56.4%54.2%55.8%53.5%55.9%55.4%55.9%55.0%
Operating Income (EBIT)$411M$313M$332M$247M$468M$395M$332M$318M
Operating Margin %15.5%11.5%12.7%9.5%18.9%15.8%13.5%12.7%
Net Income$0M$185M$217M$237M$176M$350M$284M$263M$223M
Net Margin %0.0%7.0%8.0%9.1%6.8%14.1%11.3%10.7%8.9%
EBITDA$565M$521M$665M$612M$773M$616M$629M$641M
Earnings Per Share (EPS)$0.00$0.38$0.44$0.48$0.35$0.70$0.57$0.53$0.45
Shares Outstanding (M)490M492M496M498M498M498M498M497M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALC Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Cash from Operations (CFO)$2.3B$2.3B$2.1B$1.4B$1.2B$1.3B$823M$920M$1.1B$1.2B$1.2B$1.3B
Capital Expenditures (CapEx)$663M$670M$851M$745M$1.2B$567M$676M$712M$496M$506M$486M
Free Cash Flow (FCF)$1.6B$1.6B$1.4B$537M$472M$165M$256M$244M$428M$722M$739M$832M
FCF Margin %15.2%15.5%14.2%5.7%5.4%2.0%3.8%3.2%6.0%10.6%11.2%12.8%
Dividends Paid$166M$130M$116M$100M$54M$54M$54M$54M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALC Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$510M$410M$658M$699M$505M$384M$463M$725M$530M
Capital Expenditures (CapEx)$136M$201M$160M$133M$140M$150M$111M$120M
Free Cash Flow (FCF)$370M$274M$457M$539M$372M$244M$313M$613M$410M
FCF Margin %13.1%10.3%16.8%20.6%14.3%9.9%12.5%25.0%16.4%
Dividends Paid$0M$5M$166M$2M$6M$130M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALC Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Total Assets$31.1B$31.6B$30.3B$29.6B$29.2B$28.0B$27.6B$27.7B$27.1B$27.4B$27.7B$28.2B
Cash & Cash Equivalents$1.4B$1.5B$1.7B$1.1B$980M$1.6B$1.6B$822M$227M$172M$162M$285M
Total Liabilities$9.5B$9.5B$8.8B$9.0B$9.5B$8.7B$8.8B$8.4B$4.4B$4.4B$4.7B$4.6B
Total Debt (Short + Long-Term)$5.3B$655M$4.7B$4.7B$4.7B$4.1B$4.2B$3.5B$1.9B$65M$170M$227M
Total Shareholders' Equity$21.6B$22.0B$21.6B$20.6B$19.7B$19.3B$18.8B$19.3B$22.6B$23.0B$23.0B$23.6B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALC viewer.

ALC Metric Deep Dives

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← ALBTAll “A” companiesALCO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.